Literature DB >> 15026190

CYP51--the omnipotent P450.

Galina I Lepesheva1, Michael R Waterman.   

Abstract

Sterol 14 alpha-demethylase (CYP51) is the single cytochrome P450 (CYP) required for sterol biosynthesis in different phyla, and it is the most widely distributed P450 gene family being found in all biological kingdoms. It catalyzes the first step following cyclization in sterol biosynthesis such as removal of the 14 alpha-methyl group from lanosterol in the cholesterol biosynthetic pathway, leading to formation of the initial substrate in steroid hormone biosynthesis. CYP51 from different phyla have low sequence similarity across kingdoms and contain only about 40 conserved amino acid residues in the whole family. An attempt to predict the possible role of these conserved residues is being made by a combination of the results of site-directed mutagenesis and information from the known crystal structure of sterol 14 alpha-demethylase from Mycobacterium tuberculosis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15026190     DOI: 10.1016/j.mce.2003.11.016

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  29 in total

1.  Substrate preferences and catalytic parameters determined by structural characteristics of sterol 14alpha-demethylase (CYP51) from Leishmania infantum.

Authors:  Tatiana Y Hargrove; Zdzislaw Wawrzak; Jialin Liu; W David Nes; Michael R Waterman; Galina I Lepesheva
Journal:  J Biol Chem       Date:  2011-05-31       Impact factor: 5.157

2.  Steroids, triterpenoids and molecular oxygen.

Authors:  Roger E Summons; Alexander S Bradley; Linda L Jahnke; Jacob R Waldbauer
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2006-06-29       Impact factor: 6.237

Review 3.  Sterol 14alpha-demethylase cytochrome P450 (CYP51), a P450 in all biological kingdoms.

Authors:  Galina I Lepesheva; Michael R Waterman
Journal:  Biochim Biophys Acta       Date:  2006-08-02

4.  Characterization of 1-Aminobenzotriazole and Ketoconazole as Novel Inhibitors of Monoamine Oxidase (MAO): An In Vitro Investigation.

Authors:  Abdul Naveed Shaik; Barbara W LeDuc; Ansar A Khan
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2017-10       Impact factor: 2.441

5.  Spin equilibrium and O₂-binding kinetics of Mycobacterium tuberculosis CYP51 with mutations in the histidine-threonine dyad.

Authors:  Gareth K Jennings; Anuja Modi; Justin E Elenewski; Caroline M Ritchie; Thuy Nguyen; Keith C Ellis; John C Hackett
Journal:  J Inorg Biochem       Date:  2014-04-12       Impact factor: 4.155

6.  Proteins differentially expressed during limonene biotransformation by Penicillium digitatum DSM 62840 were examined using iTRAQ labeling coupled with 2D-LC-MS/MS.

Authors:  Lu-Lu Zhang; Yan Zhang; Jing-Nan Ren; Yan-Long Liu; Jia-Jia Li; Ya-Nan Tai; Shu-Zhen Yang; Si-Yi Pan; Gang Fan
Journal:  J Ind Microbiol Biotechnol       Date:  2016-08-18       Impact factor: 3.346

7.  Complexes of Trypanosoma cruzi sterol 14α-demethylase (CYP51) with two pyridine-based drug candidates for Chagas disease: structural basis for pathogen selectivity.

Authors:  Tatiana Y Hargrove; Zdzislaw Wawrzak; Paul W Alexander; Jason H Chaplin; Martine Keenan; Susan A Charman; Catherine J Perez; Michael R Waterman; Eric Chatelain; Galina I Lepesheva
Journal:  J Biol Chem       Date:  2013-09-18       Impact factor: 5.157

8.  Regulation of cholesterologenesis by the oxysterol receptor, LXRalpha.

Authors:  Yongjun Wang; Pamela M Rogers; Chen Su; Gabor Varga; Keith R Stayrook; Thomas P Burris
Journal:  J Biol Chem       Date:  2008-08-01       Impact factor: 5.157

9.  Identification, modeling and ligand affinity of early deuterostome CYP51s, and functional characterization of recombinant zebrafish sterol 14α-demethylase.

Authors:  Ann Michelle Stanley Morrison; Jared V Goldstone; David C Lamb; Akira Kubota; Benjamin Lemaire; John J Stegeman
Journal:  Biochim Biophys Acta       Date:  2013-12-19

10.  Organocatalytic, enantioselective synthesis of VNI: a robust therapeutic development platform for Chagas, a neglected tropical disease.

Authors:  Mark C Dobish; Fernando Villalta; Michael R Waterman; Galina I Lepesheva; Jeffrey N Johnston
Journal:  Org Lett       Date:  2012-12-07       Impact factor: 6.005

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.